249 related articles for article (PubMed ID: 25927527)
21. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Mao YP; Tang LL; Chen L; Sun Y; Qi ZY; Zhou GQ; Liu LZ; Li L; Lin AH; Ma J
Chin J Cancer; 2016 Dec; 35(1):103. PubMed ID: 28031050
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
Tian YM; Guan Y; Xiao WW; Zeng L; Liu S; Lu TX; Zhao C; Han F
Head Neck; 2016 Feb; 38(2):225-31. PubMed ID: 25244494
[TBL] [Abstract][Full Text] [Related]
23. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
Luo Y; Gao Y; Yang G; Lang J
Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
[TBL] [Abstract][Full Text] [Related]
24. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
[TBL] [Abstract][Full Text] [Related]
25. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
Liu K; Han Y; Ma B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1177-83. PubMed ID: 24616996
[TBL] [Abstract][Full Text] [Related]
26. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
27. Tumor volume is not an independent prognostic factor in early-stage nasopharyngeal carcinoma treated by radiotherapy alone.
Chua DT; Sham JS; Leung LH; Tai KS; Au GK
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1437-44. PubMed ID: 15050321
[TBL] [Abstract][Full Text] [Related]
28. Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma.
Zou X; Han F; Ma WJ; Deng MQ; Jiang R; Guo L; Liu Q; Mai HQ; Hong MH; Chen MY
Head Neck; 2015 Aug; 37(8):1108-15. PubMed ID: 24764204
[TBL] [Abstract][Full Text] [Related]
29. Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
Liu F; Luo T; Jin T; Zhang J; Xiang Z; Yan R; Xie L; Wu X; Zhang H; Wang F; Li P; Liu L
BMC Cancer; 2019 Jun; 19(1):554. PubMed ID: 31176358
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of primary gross tumor volume and standardized uptake value of
Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
[TBL] [Abstract][Full Text] [Related]
32. The Value of Tumor Diameter in Predicting Prognosis of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
Niu ZJ; Li T; Liang ZG; Chen XQ; Zhao W; Zhu XD
Otolaryngol Head Neck Surg; 2017 Feb; 156(2):305-311. PubMed ID: 28145845
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
[TBL] [Abstract][Full Text] [Related]
34. Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era.
Kong L; Wang L; Shen C; Hu C; Wang L; Lu JJ
Sci Rep; 2016 Sep; 6():32883. PubMed ID: 27616024
[TBL] [Abstract][Full Text] [Related]
35. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy.
Wu Z; Zeng RF; Su Y; Gu MF; Huang SM
Head Neck; 2013 May; 35(5):689-94. PubMed ID: 22715047
[TBL] [Abstract][Full Text] [Related]
37. Magnetic Resonance Imaging-Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
Cao C; Luo J; Gao L; Yi J; Huang X; Li S; Xiao J; Zhang Z; Xu G
Cancer Res Treat; 2017 Apr; 49(2):518-525. PubMed ID: 27554478
[TBL] [Abstract][Full Text] [Related]
38. Establishment of prognostic factors in recurrent nasopharyngeal carcinoma patients who received salvage intensity-modulated radiotherapy: A meta-analysis.
Yue Q; Zhang M; Chen Y; Zheng D; Chen Y; Feng M
Oral Oncol; 2018 Jun; 81():81-88. PubMed ID: 29884418
[TBL] [Abstract][Full Text] [Related]
39. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma.
Chen HY; Ma XM; Ye M; Hou YL; Xie HY; Bai YR
PLoS One; 2013; 8(9):e73918. PubMed ID: 24040115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
